Search Results - "MCFADDEN, Eugène P"

Standardized End Point Definitions for Coronary Intervention Trials by Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W

“…Abstract The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed…”
Get full text

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document by Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W

“…The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007,…”
Get full text

High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography by MOLLET, Nico R, CADEMARTIRI, Filippo, VAN MIEGHEM, Carlos A. G, RUNZA, Giuseppe, MCFADDEN, Eugène P, BAKS, Timo, SERRUYS, Patrick W, KRESTIN, Gabriel P, DE FEYTER, Pim J

“…The diagnostic performance of the latest 64-slice CT scanner, with increased temporal (165 ms) and spatial (0.4 mm3) resolution, to detect significant stenoses…”
Get full text

Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention by Garcia-Garcia, Hector M., McFadden, Eugène P., von Birgelen, Clemens, Rademaker-Havinga, Tessa, Spitzer, Ernest, Kleiman, Neal S., Cohen, David J., Kennedy, Kevin F., Camenzind, Edoardo, Mauri, Laura, Steg, Philippe Gabriel, Wijns, William, Silber, Sigmund, van Es, Gerrit-Anne, Serruys, Patrick W., Windecker, Stephan, Cutlip, Donald, Vranckx, Pascal

“…This study sought to explore the association between biomarker elevation, with creatine kinase–myocardial band (CK-MB) or cardiac troponin (cTn), following…”
Get full text

The Target Vessel SYNTAX Score: A Simple Additional Predictor of Renal Risk in Patients Undergoing Rotational Atherectomy? by McFadden, Eugène P., Radhakrishna, Avinash

Get full text

Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes by Franzone, Anna, McFadden, Eugène P., Leonardi, Sergio, Piccolo, Raffaele, Vranckx, Pascal, Serruys, Patrick W., Hamm, Christian, Steg, Philippe Gabriel, Heg, Dik, Branca, Mattia, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco

Get full text

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy by McFadden, Eugène P, Stabile, Eugenio, Regar, Evelyn, Cheneau, Edouard, Ong, Andrew TL, Kinnaird, Timothy, Suddath, William O, Weissman, Neil J, Torguson, Rebecca, Kent, Kenneth M, Pichard, August D, Satler, Lowell F, Waksman, Ron, Serruys, Patrick W

“…Although the safety profiles of coronary stents eluting sirolimus or paclitaxel do not seem to differ from those of bare metal stents in the short-to-medium…”
Get full text

PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY by Gragnano, Felice, Heg, Dik, Franzone, Anna, McFadden, Eugène P, Leonardi, Sergio, Piccolo, Raffaele, Vranckx, Pascal, Branca, Mattia, Serruys, Patrick W, Benit, Edouard, Liebetrau, Christoph, Janssens, Luc, Ferrario, Maurizio, Zurakowski, Aleksander, Diletti, Roberto, Dominici, Marcello, Huber, Kurt, Slagboom, Ton, Buszman, Paweł, Bolognese, Leonardo, Tumscitz, Carlo, Bryniarski, Krzysztof, Aminian, Adel, Vrolix, Mathias, Petrov, Ivo, Garg, Scot, Naber, Christoph, Prokopczuk, Janusz, Hamm, Christian, Steg, Philippe Gabriel, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco

“…Abstract Aims The five-item PRECISE-DAPT, integrating age, haemoglobin, white-blood-cell count, creatinine clearance, and prior bleeding, predicts bleeding…”
Get full text

Periprocedural Myocardial Injury: Pathophysiology, Prognosis, and Prevention by Soud, Mohamad, Ho, Gavin, Hideo-Kajita, Alexandre, Yacob, Omar, Waksman, Ron, McFadden, Eugène P., Garcia-Garcia, Hector M.

“…The definition and clinical implications of myocardial infarction occurring in the setting of percutaneous coronary intervention have been the subject of…”
Get full text

Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients by Soud, Mohamad, Hideo-Kajita, Alexandre, Ho, Gavin, Yacob, Omar, Alahdab, Fares, King, Fred, Waksman, Ron, McFadden, Eugène P., Garcia-Garcia, Hector M.

“…BACKGROUNDUncertainty remains regarding the exact prognostic impact of biomarker elevation following percutaneous coronary intervention in patients with stable…”
Get full text

Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities : The integrated biomarker and imaging study (IBIS) by VAN MIEGHEM, Carlos A. G, MCFADDEN, Eugène P, VALGIMIGLI, Marco, MASTIK, Frits, VAN DER STEEN, Anton F, VAN DER GIESSEN, Willem J, SIANOS, Georgios, BACKX, Bianca, MOREL, Marie-Angèle M, VAN ES, Gerrit-Anne, ZALEWSKI, Andrew, SERRUYS, Patrick W, DE FEYTER, Pim J, BRUINING, Nico, SCHAAR, Johannes A, MOLLET, Nico R, CADEMARTIRI, Filippo, GOEDHART, Dick, DE WINTER, Sebastiaan, RODRIGUEZ GRANILLO, Gaston

“…Our purpose was to assess noninvasive imaging in detection of subclinical atherosclerosis and to examine novel invasive modalities to describe prevalence and…”
Get full text

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS by Valgimigli, Marco, Bueno, Héctor, Byrne, Robert A, Collet, Jean-Philippe, Costa, Francesco, Jeppsson, Anders, Jüni, Peter, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, Montalescot, Gilles, Neumann, Franz-Josef, Petricevic, Mate, Roffi, Marco, Steg, Philippe Gabriel, Windecker, Stephan, Zamorano, Jose Luis, Levine, Glenn N

Get full text

effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients by Van Belle, Eric, Périé, Marc, Braune, David, Chmaït, Akram, Meurice, Thibaud, Abolmaali, Kaveh, McFadden, Eugène P., Bauters, Christophe, Lablanche, Jean-Marc, Bertrand, Michel E.

“…We sought to compare coronary stent implantation with balloon angioplasty (BA), in a diabetic population, in terms of the six-month angiographic outcome and…”
Get full text

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting : The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study by BERTRAND, M. E, LEGRAND, V, NICCOLI, L, OTO, A, WHITE, C, WEBB-PEPLOE, M, VAN BELLE, E, MCFADDEN, E. P, BOLAND, J, FLECK, E, BONNIER, J, EMMANUELSON, H, VROLIX, M, MISSAULT, L, CHIERCHIA, S, CASACCIA, M

“…Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more effective than conventional anticoagulation in patients with an optimal…”
Get full text

Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up : A key determinant of survival in diabetics after coronary balloon angioplasty by VAN BELLE, Eric, KETELERS, Régis, BAUTERS, Christophe, PERIE, Marc, ABOLMAALI, Kaveh, RICHARD, Florence, LABLANCHE, Jean-Marc, MCFADDEN, Eugène P, BERTRAND, Michel E

“…Several reports have demonstrated a high mortality rate in diabetic patients treated by standard coronary balloon angioplasty. No clear explanation has been…”
Get full text

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials by Valgimigli, Marco, Gragnano, Felice, Branca, Mattia, Franzone, Anna, Baber, Usman, Jang, Yangsoo, Kimura, Takeshi, Hahn, Joo-Yong, Zhao, Qiang, Windecker, Stephan, Gibson, Charles M, Kim, Byeong-Keuk, Watanabe, Hirotoshi, Song, Young Bin, Zhu, Yunpeng, Vranckx, Pascal, Mehta, Shamir, Hong, Sung-Jin, Ando, Kenji, Gwon, Hyeon-Cheol, Serruys, Patrick W, Dangas, George D, McFadden, Eùgene P, Angiolillo, Dominick J, Heg, Dik, Jüni, Peter, Mehran, Roxana

“…To assess the risks and benefits of P2Y inhibitor monotherapy compared with dual antiplatelet therapy (DAPT) and whether these associations are modified by…”
Get more information

Predictors of Restenosis After Coronary Stent Implantation by Bauters, Christophe, Hubert, Edouard, Prat, Alain, Bougrimi, Karim, Van Belle, Eric, McFadden, Eugène P, Amouyel, Philippe, Lablanche, Jean-Marc, Bertrand, Michel

“…Objectives. We sought to determine predictors of restenosis after coronary stenting (CS) in a consecutive series of patients. Background. Although stenting in…”
Get full text

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions by Gragnano, Felice, Mehran, Roxana, Branca, Mattia, Franzone, Anna, Baber, Usman, Jang, Yangsoo, Kimura, Takeshi, Hahn, Joo-Yong, Zhao, Qiang, Windecker, Stephan, Gibson, Charles M., Kim, Byeong-Keuk, Watanabe, Hirotoshi, Song, Young Bin, Zhu, Yunpeng, Vranckx, Pascal, Mehta, Shamir, Hong, Sung-Jin, Ando, Kenji, Gwon, Hyeon-Cheol, Calabrò, Paolo, Serruys, Patrick W., Dangas, George D., McFadden, Eùgene P., Angiolillo, Dominick J., Heg, Dik, Valgimigli, Marco

“…It remains unclear whether P2Y12 inhibitor monotherapy preserves ischemic protection while limiting bleeding risk compared with dual antiplatelet therapy…”
Get full text

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events by Gragnano, Felice, Cao, Davide, Pirondini, Leah, Franzone, Anna, Kim, Hyo-Soo, von Scheidt, Moritz, Pettersen, Alf-Åge R., Zhao, Qiang, Woodward, Mark, Chiarito, Mauro, McFadden, Eugene P., Park, Kyung Woo, Kastrati, Adnan, Seljeflot, Ingebjørg, Zhu, Yunpeng, Windecker, Stephan, Kang, Jeehoon, Schunkert, Heribert, Arnesen, Harald, Bhatt, Deepak L., Steg, Philippe Gabriel, Calabrò, Paolo, Pocock, Stuart, Mehran, Roxana, Valgimigli, Marco

“…Aspirin is the only antiplatelet agent with a Class I recommendation for long-term prevention of cardiovascular events in patients with coronary artery disease…”
Get full text

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC) by Valgimigli, Marco, Garcia-Garcia, Hector M, Vrijens, Bernard, Vranckx, Pascal, McFadden, Eugène P, Costa, Francesco, Pieper, Karen, Vock, David M, Zhang, Min, Van Es, Gerrit-Anne, Tricoci, Pierluigi, Baber, Usman, Steg, Gabriel, Montalescot, Gilles, Angiolillo, Dominick J, Serruys, Patrick W, Farb, Andrew, Windecker, Stephan, Kastrati, Adnan, Colombo, Antonio, Feres, Fausto, Jüni, Peter, Stone, Gregg W, Bhatt, Deepak L, Mehran, Roxana, Tijssen, Jan G P

“…Non-adherence has been well recognized for years to be a common issue that significantly impacts clinical outcomes and health care costs. Medication adherence…”
Get full text